The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
2 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $872,235 in first-year total cost, median $436,118.
Most frequent study sections
- Special Emphasis Panel[ZRG1 EMNR-S (55)]1
- Special Emphasis Panel[ZRG1 EMNR-S (56)]1
Most frequent institutions
- UNIVERSITY OF WASHINGTON1
- VANDERBILT UNIVERSITY MEDICAL CENTER1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2021 | Repurposing Azithromycin for premature brain injury1R01HD101422-01A1 | WOOD, THOMAS | UNIVERSITY OF WASHINGTON, WA | $429,623 | ZRG1 |
| 2019 | Pre-clinical studies to repurpose FDA-approved drugs for tocolytic use1R01HD098213-01 | HERINGTON, JENNIFER L. | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $442,612 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.